Clinical Efficacy and Safety Evaluation of HCP1904-3 in Essential Hypertension Patients
Clinical trial NCT05199129 · COMPLETED
Trial details
- NCT number
- NCT05199129
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-17
- Primary completion
- 2022-09-14
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.